Cyanidin-3-glucoside (Anthocyanin)

Cyanidin-3-glucoside is an anthocyanin flavonoid that activates Nrf2 antioxidant pathways and modulates glucose metabolism. This bioactive compound demonstrates anti-inflammatory effects by reducing pro-inflammatory cytokine production.

Origin & History

Cyanidin-3-glucoside (C3G) is an anthocyanin compound naturally found in pigmented fruits and plants including black beans (Phaseolus vulgaris), berries, mulberries, and red grapes, where it serves as the pigment responsible for red, purple, and blue colors. Commercial extraction typically involves solvent-based methods from plant sources like black bean seed coats, followed by purification processes.

Historical & Cultural Context

The research dossier indicates no historical or traditional medicine uses specifically for C3G. It is referenced only as a naturally occurring bioactive compound from anthocyanin-rich plants, with focus on modern research applications rather than traditional medicinal systems.

Health Benefits

• Glucose regulation: Animal studies show 87.5% of diabetic rodent models experienced glucose reduction, though human trials are needed
• Antioxidant protection: Activates Nrf2 pathways to modulate oxidative stress and DNA damage (preclinical evidence)
• Anti-inflammatory effects: Reduces pro-inflammatory cytokines by 50% (TNF-α) and 30% (IL-6) in neutrophil models
• Lipid metabolism: Decreases lipid synthesis and increases fatty acid oxidation via PI3K/AKT signaling (animal studies)
• Gut microbiome modulation: Decreases Firmicutes and increases Bacteroidetes populations (preclinical data)

How It Works

Cyanidin-3-glucoside activates the Nrf2 transcription factor pathway, enhancing cellular antioxidant enzyme production and reducing oxidative DNA damage. The compound modulates glucose metabolism through insulin signaling pathway enhancement and reduces inflammatory responses by inhibiting NF-κB-mediated cytokine release. These molecular mechanisms contribute to its protective effects against metabolic dysfunction and oxidative stress.

Scientific Research

Human clinical evidence is limited to one pharmacokinetic study using black bean seed coat extract over 2 weeks, confirming absorption with no serious adverse events. Systematic reviews note promising results from 16 diabetic rodent studies but emphasize the critical need for human randomized controlled trials, as no RCTs or meta-analyses on efficacy outcomes were identified.

Clinical Summary

Animal studies demonstrate that cyanidin-3-glucoside achieved glucose reduction in 87.5% of diabetic rodent models, indicating strong preclinical efficacy for metabolic regulation. Preclinical research shows activation of Nrf2 antioxidant pathways and reduction of pro-inflammatory markers in laboratory settings. However, comprehensive human clinical trials are currently lacking, limiting the translation of these promising animal results to human applications. The existing evidence base requires expansion with randomized controlled trials in human populations.

Nutritional Profile

Cyanidin-3-glucoside (C3G) is a pure polyphenolic compound (anthocyanin subclass), not a whole food, so traditional macronutrient/micronutrient profiling does not apply. Key compositional data: Molecular weight 449.2 g/mol; chemical formula C21H21O11+. Bioactive concentration in food sources varies significantly — blueberries contain approximately 0.1–0.5 mg/g fresh weight, black rice bran 0.5–3.0 mg/g dry weight, elderberries 0.4–1.0 mg/g fresh weight, and blackcurrants 0.3–0.8 mg/g fresh weight. As an isolated compound, it is 100% bioactive anthocyanin with no fat, protein, or fiber content. Bioavailability is notably low and variable: oral bioavailability estimates range from 0.1–1.8% in human studies, with peak plasma concentrations (Cmax) typically reaching 1–50 nmol/L after dietary intake. Absorption occurs primarily in the stomach and small intestine via bilitranslocase and glucose transporters (SGLT1, GLUT2). Extensive first-pass metabolism converts C3G to protocatechuic acid and phloroglucinol aldehyde, which are the primary circulating metabolites contributing to systemic effects. Co-ingestion with dietary fat or vitamin C has been shown to modestly improve absorption by approximately 15–20%. Stability is pH-dependent — degradation accelerates above pH 6, limiting small intestinal absorption. Half-life in plasma is approximately 1.5–2 hours post-ingestion.

Preparation & Dosage

Human dosage data is limited to one pharmacokinetic trial using black bean seed coat extract for 2 weeks (specific C3G content not quantified). No standardized dosage ranges have been established from human clinical trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Other anthocyanins, vitamin C, quercetin, resveratrol, green tea catechins

Safety & Interactions

Cyanidin-3-glucoside appears generally well-tolerated based on its natural occurrence in berries and other foods. No significant adverse effects have been reported in animal studies at therapeutic doses. Potential interactions with diabetes medications may occur due to glucose-lowering effects, requiring medical supervision for diabetic patients. Safety data during pregnancy and lactation is insufficient, warranting caution in these populations.